絞り込み

18454

広告

Expression of PD-1/PD-L1 in children's classical Hodgkin lymphomas.

著者 Dilly-Feldis M , Aladjidi N , Refait JK , Parrens M , Ducassou S , Rullier A
Pediatr Blood Cancer.2019 Jan 13 ; ():e27571.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (15view , 0users)
Although a prognosis of recurrent or refractory childhood Hodgkin lymphoma (HL) is associated with poor outcomes despite intensive therapy, the immune checkpoint inhibitors PD-1/PD-L1 appear to be therapeutic alternatives for advanced adult cases. However, these pharmacotherapies are yet to be studied in a pediatric population.
PMID: 30637917 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード